logo
EXCLUSIVE Patient, 56, dies from colon cancer after just ONE WEEK as doctors reveal key warning signs

EXCLUSIVE Patient, 56, dies from colon cancer after just ONE WEEK as doctors reveal key warning signs

Daily Mail​4 hours ago

A man diagnosed with colon cancer after just a week of symptoms died in one of the world's most aggressive cases.
The 56-year-old from Lebanon visited his local hospital after a week of constipation and bloating.
A colonoscopy revealed a cancerous tumor in his sigmoid colon, the lowest part of the colon that meets the rectum.
Doctors also found multiple lesions in the man's liver, suggesting the cancer was already 'at an advanced stage' despite symptoms starting so suddenly.
The man was diagnosed with a colonic sarcomatoid carcinoma, an extremely rare and aggressive cancer that can take over the body in just weeks.
No more than 50 cases like the man's have been reported in medical literature, and the disease is thought to kill most patients in less than six months.
In similar cases, patients have died just 30 days after being diagnosed with no time to receive treatments.
The unnamed man was unable to start chemotherapy before returning to the hospital days later with a fever. He died about a week later.
Writing in a medical journal this week, doctors treating the man said there is a 'huge need for further research' on colonic sarcomatoid carcinomas to develop treatments and stop the disease from becoming a death sentence.
Sarcomatoid carcinomas are made up of both carcinoma - cancer of the epithelial tissue, which lines organs - and sarcoma - cancer of connective tissues like bones.
It most commonly forms in the lungs, though it only makes up 0.1 percent of all lung tumors.
Doctors treating the man said sarcomatoid carcinomas are rare in the digestive tract. They're also the most aggressive with an average survival rate of five months.
The medical team noted this could be because these tumors are more likely to spread and be resistant to chemotherapy, and most patients are already at an advanced stage by the time they receive a diagnosis.
There are no specific treatment guidelines for sarcomatoid carcinomas.
Like more common forms of colon cancer, diet, sedentary lifestyle and conditions like diabetes and obesity can raise the risk of the disease by creating inflammation in the digestive tract, which leads to cell DNA damage and dangerous mutations forming.
The patient was a heavy smoker with high blood pressure, uncontrolled type 2 diabetes and an enlarged prostate. It's unclear if he had any genetic mutations linked to colon cancer.
Smoking also introduces about 7,000 carcinogens into the body that attack DNA and lead to polyps forming in the colon, which can turn into cancerous lesions.
The man's case comes as 154,000 Americans are expected to be diagnosed with colorectal cancer this year, including 20,000 under 50 years old.
And the latest data shows early-onset colorectal cancer diagnoses in the US are expected to rise 90 percent in people 20 to 34 years old between 2010 and 2030.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

A rundown of recent Trump administration vaccine policy changes
A rundown of recent Trump administration vaccine policy changes

The Independent

time21 minutes ago

  • The Independent

A rundown of recent Trump administration vaccine policy changes

The Trump administration continued to reshape U.S. health policy in recent days with several moves that could change what vaccines people can get to protect themselves from common illnesses. Some of the changes are immediate, others are still being discussed, and Health Secretary Robert F. Kennedy Jr. must still sign off on some. Doctors' groups have expressed alarm at the moves made by Kennedy, a longtime anti-vaccine activist, and his appointees, who at times have ignored well-established science. Nearly 80 medical groups, including the American Medical Association, issued a statement backing vaccines against common respiratory ailments as 'among the best tools to protect the public.' 'We come together as physicians from every corner of medicine to reaffirm our commitment to these lifesaving vaccines,' the groups wrote. Here's what to know about some of the recent vaccine policy changes: Flu shots and thimerosal On Thursday, a vaccine advisory group handpicked by Kennedy recommended that just about every American get a flu shot this fall. But the group also said people should avoid shots containing thimerosal, a preservative used only in large multi-dose vials that has been proven to be safe. The ingredient isn't used in single-dose flu shots, the type of syringe used for about 95% of U.S. flu shots last season. Status: Kennedy must sign off on the recommendations. Read more AP coverage here. How to get a COVID-19 shot Universal access to updated COVID-19 shots for the fall remains unclear, even after Kennedy's vaccine advisers were shown data showing how well the vaccines are working. Kennedy changed CDC guidance last month, saying the shots are no longer recommended for healthy children and pregnant women — even though doctors groups disagree. And the Food and Drug Administration has moved to limit COVID-19 vaccinations among healthy people under age 65. Status: Upcoming advisory meetings, regulatory decisions and policies from insurers and employers are likely to influence access. Read more AP coverage here. Expanded warnings on COVID-19 vaccine labels At the request of the FDA, makers of the two leading COVID-19 vaccines on Wednesday expanded existing warnings about a rare heart side effect mainly seen in young men. Prescribing information from both Pfizer and Moderna had already advised doctors about rare cases of myocarditis, a type of heart inflammation that is usually mild. The FDA had asked the drugmakers to add more detail about the problem and to cover a larger group of patients. Status: Labels are being updated now. Read more AP coverage here. Changes considered for the childhood vaccine schedule On Wednesday, Kennedy's vaccine advisers said they would be evaluating the 'cumulative effect' of the children's vaccine schedule — the list of immunizations given at different times throughout childhood. The announcement reflected vaccine skeptics' messaging: that too many shots may overwhelm kids' immune systems. Scientists say those claims have been repeatedly investigated with no signs of concern. The American Academy of Pediatrics said it would continue publishing its own vaccine schedule for children but now will do so independently of the government advisory panel, calling it 'no longer a credible process.' Status: The examination is in its early stages. Read more AP coverage here. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

Ethical questions surround the NHS sampling babies' DNA
Ethical questions surround the NHS sampling babies' DNA

The Guardian

timean hour ago

  • The Guardian

Ethical questions surround the NHS sampling babies' DNA

Re your report (All babies in England to get DNA test to assess risk of diseases within 10 years, 20 June), the NHS plans to test the DNA of all babies to 'assess disease risk', in association with AI, having already sampled 100,000 newborns. The Department of Health and Social Care said that genomics and AI would be used to 'revolutionise prevention' and provide faster diagnoses and an 'early warning signal for disease'. In line with previous predictions, when individuals who submitted to a PCR test (which amplifies genetic material) during Covid-19 had their DNA sold for profit without their consent, infants now face their private, personal, biological data being captured, stored and used by who-knows-what corporations on behalf of the NHS. Not everyone wants to know what potential diseases they might suffer from in the future, especially if there is no known treatment. And for what purposes might it be used, other than 'prediction of disease risk'? Testing of new drugs? Testing of vaccines? Clearly an infant cannot give consent to its DNA being used for these purposes and research on children is unethical unless they stand to benefit. Will parents have the opportunity to give informed consent and can it even be informed if they are unaware of the many potential uses of the material? A global genomics market of $32.65bn in 2023 suggests that this is big business. Genomics England already makes available patients' genomic data to businesses. The association with AI additionally raises the spectre of surveillance in the form of digital IDs, incorporating not only biometric data, such as fingerprints, retinal scans and facial recognition, but potentially even the human genome itself. The NHS data of 57 million patients has already been used to train AI outside of the intended purpose. Will doctors recognise these risks and take steps to inform patients? Or will technology roll on regardless?Janet MenageRetired GP, Llanybydder, Ceredigion Have an opinion on anything you've read in the Guardian today? Please email us your letter and it will be considered for publication in our letters section.

A clear set of actions is needed to improve NHS maternity services
A clear set of actions is needed to improve NHS maternity services

The Guardian

timean hour ago

  • The Guardian

A clear set of actions is needed to improve NHS maternity services

This inquiry (Wes Streeting announces investigation into 'failing' NHS maternity services, 23 June) needs to get to the heart of why NHS maternity services in England are falling far short of where they need to be. It must leave no stone unturned; there are significant, systemic challenges that affect trusts' ability to consistently deliver high-quality care, deep-rooted issues with morale and culture within maternity services and, as you highlight (Editorial, 23 June), the 'shockingly higher risk of mortality faced by black and Asian mothers' and those from more deprived backgrounds. There have been innumerable recommendations and a regulatory landscape that has become complex, distracting and difficult for trusts to navigate. Trust leaders will welcome proposals to introduce one clear set of actions to improve care across every NHS maternity CorderyDeputy chief executive, NHS Providers After a number of years overseeing maternity and perinatal services at regional level, this proposal frustrates me. The inquiry is purely politically motivated and will not add any value to the women, babies and families affected previously or who may be in the future. Multiple strategic transformation programmes have been commissioned and funded. There is nothing new to discover; obstetricians focus on healthy babies, midwives focus on happy mothers. The medical v social models of care make this an impossible divide, not helped by either group frequently failing to listen and respond effectively to women's concerns. Perhaps when there are sufficient staff to work together as a team, and we place the woman at the centre of care and an effective digital infrastructure is in place to support effective communication, instead of focusing on the either/or approach of 'high risk' v 'low risk', we might get PearsonGatley, Cheshire We do not need another review of failing maternity services. The national service development funding (SDF) for maternity services will be cut from £95m in 2024-25 to just £2m in 2025-26. The patriarchy rules and as a consequence misogyny sets the tone for maternity care. Why else would there be gynaecology beds for women experiencing miscarriage, ectopic pregnancy or termination on a postnatal ward?Zoe GreenLondon Although failures in maternity care are of great concern, rather than simply chasing after the evidence of what failures look like and castigating those accused of 'passing the buck', perhaps Wes Streeting should also look at the 10 best performing units to find out what they do and how they achieve success. That might prove informative and more inspirational than (once again) punishing those that GibbsEmeritus professor of inclusive educational psychology and philosophy, Newcastle University Have an opinion on anything you've read in the Guardian today? Please email us your letter and it will be considered for publication in our letters section.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store